NEWRON PHARMACEUTICALS SPA (NP5.DE) Earnings History & Surprises

FRA:NP5 • IT0004147952

Current stock price

16.55 EUR
+0.5 (+3.12%)
Last:

NP5.DE Earnings overview

Past quarterly earnings results for NEWRON PHARMACEUTICALS SPA (NP5.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
N/A
Period
Q2 / 2026
EPS Estimate
-€0.67
Revenue Estimate
6.732M

Last Reported

Most Recent
Release Date
Mar 24, 2026
Period
Q4 / 2025
EPS Reported
-€0.66
EPS Surprise
2.55%
Revenue Surprise
86.48%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in EUR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.66 -0.67 2.55% -148.24% 7.228M 3.876M 86.48% -84.94%
Q2 2025 0.00 -0.45 99.11% 99.22% 11.898M 9.119M 30.47% 249.22%
Q4 2024 1.36 1.95 -30.19% 361.54% 47.983M 48.654M -1.38% 1,246.70%
Q2 2024 -0.51 -0.51 - -30.77% 3.407M 3.672M -7.22% -37.99%
Q4 2023 -0.52 -0.50 -4.04% -4.00% 3.563M 3.468M 2.74% 9.16%
Q2 2023 -0.39 -0.58 32.92% 18.75% 5.494M 3.264M 68.32% 94.13%
Q4 2022 -0.50 -0.54 7.51% -51.52% 3.264M 3.274M -0.31% 5.60%
Q2 2022 -0.48 -0.45 -6.95% 5.88% 2.83M 3.264M -13.30% 5.95%
Q4 2021 -0.33 -0.63 47.39% 44.07% 3.091M 3.06M 1.01% 12.44%
Q2 2021 -0.51 -0.59 13.79% 13.56% 2.671M 2.55M 4.75% 6.46%
Q4 2020 -0.59 -0.71 17.37% - 2.749M 2.958M -7.07% -
Q2 2020 -0.59 -0.73 19.66% - 2.509M 2.856M -12.15% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

NP5.DE EPS Q2Q GrowthNP5.DE EPS Q2Q GrowthEPS Q2Q Growth Q2/21 Q4/21 Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 Q2/26 Q4/26 Q2/27 Q4/27 0 -5K -10K -15K

Revenue Historical Q2Q growth and Acceleration

NP5.DE Revenue Q2Q GrowthNP5.DE Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 Q4/21 Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 Q2/26 Q4/26 0 200 400 600 800 1K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

NP5.DE Overview NP5.DE Technical Analysis Report NP5.DE Fundamental Analysis Report NP5.DE Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

NEWRON PHARMACEUTICALS SPA / NP5.DE Earnings FAQ

Can you provide the last earnings date for NEWRON PHARMACEUTICALS SPA?

NEWRON PHARMACEUTICALS SPA (NP5.DE) last reported earnings on 3/24/2026.

Did NEWRON PHARMACEUTICALS SPA (NP5.DE) beat earnings estimates last quarter?

NEWRON PHARMACEUTICALS SPA (NP5.DE) beat EPS estimates and beat revenue estimates in the most recent quarter.